Jean-Pierre Sommadossi

Insider Reports History

Location
125 Summer Street, 16 Th Floor, Boston, MA
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Jean-Pierre Sommadossi
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jean-Pierre Sommadossi:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Atea Pharmaceuticals, Inc. President, CEO, and Chairman, Director Common Stock 5.87M $18M $3.06 Jan 31, 2025 Held by JPM Partners LLC
Atea Pharmaceuticals, Inc. President, CEO, and Chairman, Director Common Stock 301K $921K $3.06 Jan 31, 2025 Direct
Atea Pharmaceuticals, Inc. President, CEO, and Chairman, Director Restricted Stock Units 99.5K $305K $3.06 Jan 31, 2025 Direct
Atea Pharmaceuticals, Inc. President, CEO, and Chairman, Director Stock Option (Right to Buy) 440K Jan 31, 2025 Direct
Kezar Life Sciences, Inc. Director Stock Option (Right to Buy) 26K Jun 28, 2021 Direct
ABG Acquisition Corp. I Director Class B ordinary shares 0 Mar 1, 2023 Direct

Insider Reports Filed by Jean-Pierre Sommadossi

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVIR Atea Pharmaceuticals, Inc. Jan 31, 2025 6 -$271K 4 Feb 4, 2025 President, CEO, and Chairman, Director
AVIR Atea Pharmaceuticals, Inc. Sep 17, 2024 3 -$234K 4 Sep 19, 2024 President, CEO, and Chairman, Director
AVIR Atea Pharmaceuticals, Inc. Jun 5, 2024 1 -$4.02K 4 Jun 7, 2024 President, CEO, and Chairman, Director
AVIR Atea Pharmaceuticals, Inc. Jan 31, 2024 4 -$219K 4 Feb 2, 2024 President, CEO, and Chairman, Director
ABGI ABG Acquisition Corp. I Mar 1, 2023 1 $0 4 Mar 3, 2023 Director
AVIR Atea Pharmaceuticals, Inc. Jan 31, 2023 2 $0 4 Feb 2, 2023 President, CEO, and Chairman, Director
AVIR Atea Pharmaceuticals, Inc. Jan 31, 2022 1 $0 4 Feb 2, 2022 President, CEO, and Chairman, Director
KZR Kezar Life Sciences, Inc. Jun 28, 2021 1 $0 4 Jun 30, 2021 Director